Msm and Nasalcrom drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Msm (methylsulfonylmethane) and Nasalcrom (cromolyn sodium). Common drug interactions include disturbance in attention among females and dry eye among males.
The phase IV clinical study analyzes what interactions people have when they take Msm and Nasalcrom. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Msm?
Msm has active ingredients of methylsulfonylmethane. It is often used in joint pain. eHealthMe is studying from 1,210 Msm users. Check the latest studies of Msm.
What is Nasalcrom?
Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.
14 people who take Msm and Nasalcrom together, and have interactions are studied.
What are the common drug interactions of Msm and Nasalcrom, by gender? *:
female:
- Disturbance in attention
- Dyspnoea (difficult or laboured respiration)
- Eye haemorrhage (bleeding in the eye)
- Hypersensitivity
- Muscle spasms (muscle contraction)
- Muscle tightness
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Somnambulism (sleep walking)
- Swelling
male:
- Dry eye (lack of adequate tears)
- Vision blurred
What are the common drug interactions of Msm and Nasalcrom, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Hypomania (a mild form of mania, marked by elation and hyperactivity)
- Tooth discolouration (a change in colour of teeth)
60+:
- Dry eye (lack of adequate tears)
- Vision blurred
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 64.29%
- Hypersensitivity: 6 people, 42.86%
- High Blood Pressure: 6 people, 42.86%
- Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 42.86%
- Ill-Defined Disorder: 5 people, 35.71%
- Stress And Anxiety: 5 people, 35.71%
- Constipation: 5 people, 35.71%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 14.29%
- Immunodeficiency Common Variable: 2 people, 14.29%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Msm and Nasalcrom?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Msm and Nasalcrom:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Msm:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nasalcrom:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Msm and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nasalcrom and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methylsulfonylmethane and cromolyn sodium (the active ingredients of Msm and Nasalcrom, respectively), and Msm and Nasalcrom (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Viibryd and Cymbalta - a second ago
- Drug interactions of Cortisone Acetate and Losartan - 6 seconds ago
- Acromegaly and Sleep Apnea Syndrome - 6 seconds ago
- Could Clopidogrel cause Breast Pain? - 11 seconds ago
- Tacrolimus vs. Azathioprine, side effect and effectiveness comparison - 14 seconds ago
- Drug interactions of B12 and Nerlynx - 16 seconds ago
- Could Armodafinil cause Flatulence? - 29 seconds ago
- Could Bactroban cause Haematochezia? - 41 seconds ago
- Drug interactions of Minocin and Ultram - 43 seconds ago
- Could Platinol cause Chest Pain? - 43 seconds ago